{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:14:40Z","timestamp":1774437280362,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601399"],"award-info":[{"award-number":["81601399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1655-8","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:35:49Z","timestamp":1539218149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Miao","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zonghui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhewei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"1655_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","volume":"7","author":"ED Mellins","year":"2011","unstructured":"Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011;7:416\u201326.","journal-title":"Nat Rev Rheumatol"},{"key":"1655_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.autrev.2011.02.001","volume":"10","author":"YT Lin","year":"2011","unstructured":"Lin YT, Wang CT, Gershwin ME, Chiang BL. The pathogenesis of oligoarticular\/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev. 2011;10:482\u20139.","journal-title":"Autoimmun Rev"},{"key":"1655_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2014.05.005","volume":"26","author":"A Avau","year":"2015","unstructured":"Avau A, Put K, Wouters CH, Matthys P. Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis. Cytokine Growth Factor Rev. 2015;26:35\u201345.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1655_CR4","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377:2138\u201349.","journal-title":"Lancet"},{"key":"1655_CR5","first-page":"515","volume":"35","author":"S Agarwal","year":"2008","unstructured":"Agarwal S, Misra R, Aggarwal A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol. 2008;35:515\u20139.","journal-title":"J Rheumatol"},{"key":"1655_CR6","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005;201:1479\u201386.","journal-title":"J Exp Med"},{"key":"1655_CR7","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2147\/DDDT.S114532","volume":"12","author":"N Toplak","year":"2018","unstructured":"Toplak N, Blazina S, Avcin T. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives. Drug Des Devel Ther. 2018;12:1633\u201343.","journal-title":"Drug Des Devel Ther."},{"key":"1655_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40272-016-0186-0","volume":"18","author":"S Blazina","year":"2016","unstructured":"Blazina S, Markelj G, Avramovic MZ, Toplak N, Avcin T. Management of juvenile idiopathic arthritis: a clinical guide. Paediatr Drugs. 2016;18:397\u2013412.","journal-title":"Paediatr Drugs"},{"key":"1655_CR9","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3899\/jrheum.090952","volume":"36","author":"RA Russo","year":"2009","unstructured":"Russo RA, Katsicas MM. Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J Rheumatol. 2009;36:1078\u201382.","journal-title":"J Rheumatol"},{"key":"1655_CR10","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F Benedetti De","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385\u201395.","journal-title":"N Engl J Med"},{"key":"1655_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/imr.12605","volume":"281","author":"G Cavalli","year":"2018","unstructured":"Cavalli G, Dinarello CA. Suppression of inflammation and acquired immunity by IL-37. Immunol Rev. 2018;281:179\u201390.","journal-title":"Immunol Rev"},{"key":"1655_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-015-0394-3","volume":"13","author":"B Chen","year":"2015","unstructured":"Chen B, Huang K, Ye L, Li Y, Zhang J, Zhang J, Fan X, Liu X, Li L, Sun J, et al. Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity. J Transl Med. 2015;13:36.","journal-title":"J Transl Med."},{"key":"1655_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1479-5876-12-69","volume":"12","author":"L Ye","year":"2014","unstructured":"Ye L, Ji L, Wen Z, Zhou Y, Hu D, Li Y, Yu T, Chen B, Zhang J, Ding L, et al. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med. 2014;12:69.","journal-title":"J Transl Med."},{"key":"1655_CR14","doi-asserted-by":"publisher","first-page":"e95346","DOI":"10.1371\/journal.pone.0095346","volume":"9","author":"PW Zhao","year":"2014","unstructured":"Zhao PW, Jiang WG, Wang L, Jiang ZY, Shan YX, Jiang YF. Plasma levels of IL-37 and correlation with TNF-alpha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS ONE. 2014;9:e95346.","journal-title":"PLoS ONE"},{"key":"1655_CR15","doi-asserted-by":"publisher","first-page":"795043","DOI":"10.1155\/2015\/795043","volume":"2015","author":"T Xia","year":"2015","unstructured":"Xia T, Zheng XF, Qian BH, Fang H, Wang JJ, Zhang LL, Pang YF, Zhang J, Wei XQ, Xia ZF, et al. Plasma interleukin-37 is elevated in patients with rheumatoid arthritis: its correlation with disease activity and Th1\/Th2\/Th17-related cytokines. Dis Markers. 2015;2015:795043.","journal-title":"Dis Markers"},{"key":"1655_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13075-018-1555-6","volume":"20","author":"H Chi","year":"2018","unstructured":"Chi H, Liu D, Sun Y, Hu Q, Liu H, Cheng X, Ye J, Shi H, Yin Y, Liu M, et al. Interleukin-37 is increased in adult-onset Still\u2019s disease and associated with disease activity. Arthritis Res Ther. 2018;20:54.","journal-title":"Arthritis Res Ther."},{"key":"1655_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","volume":"22","author":"D Boraschi","year":"2011","unstructured":"Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C, Posselt G, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw. 2011;22:127\u201347.","journal-title":"Eur Cytokine Netw"},{"key":"1655_CR18","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 2010;11:1014\u201322.","journal-title":"Nat Immunol"},{"key":"1655_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1042\/BJ20040217","volume":"381","author":"P Bufler","year":"2004","unstructured":"Bufler P, Gamboni-Robertson F, Azam T, Kim SH, Dinarello CA. Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide. Biochem J. 2004;381:503\u201310.","journal-title":"Biochem J."},{"key":"1655_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10875-012-9791-z","volume":"33","author":"L Song","year":"2013","unstructured":"Song L, Qiu F, Fan Y, Ding F, Liu H, Shu Q, Liu W, Li X. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol. 2013;33:111\u20137.","journal-title":"J Clin Immunol"},{"key":"1655_CR21","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/apm.12467","volume":"123","author":"L Yang","year":"2015","unstructured":"Yang L, Zhang J, Tao J, Lu T. Elevated serum levels of Interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis. APMIS. 2015;123:1025\u201331.","journal-title":"APMIS."},{"key":"1655_CR22","first-page":"19","volume":"23","author":"RM Fawzy","year":"2016","unstructured":"Fawzy RM, Ganeb SS, Said EA, Fouad NA. Serum level of interleukin-37 and expression of its mRNA in ankylosing spondylitis patients: possible role in osteoporosis. Egypt J Immunol. 2016;23:19\u201329.","journal-title":"Egypt J Immunol."},{"key":"1655_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/rhu.0000000000000779","author":"AM El-Barbary","year":"2018","unstructured":"El-Barbary AM, Hussein MS, Almedany SH, Rageh EM, Alsalawy AM, Aboelhawa MA, Elkholy RM, Shafik NM, Elharoun AS. Role of interleukin 37 as a novel proangiogenic factor in juvenile idiopathic arthritis. J Clin Rheumato. 2018. https:\/\/doi.org\/10.1097\/rhu.0000000000000779 .","journal-title":"J Clin Rheumato."},{"key":"1655_CR24","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"1655_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, Malattia C, Viola S, Martini A, Ravelli A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61:658\u201366.","journal-title":"Arthritis Rheum"},{"key":"1655_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/039463201202500105","volume":"25","author":"S Tete","year":"2012","unstructured":"Tete S, Tripodi D, Rosati M, Conti F, Maccauro G, Saggini A, Cianchetti E, Caraffa A, Antinolfi P, Toniato E, et al. IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol. 2012;25:31\u20138.","journal-title":"Int J Immunopathol Pharmacol."},{"key":"1655_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/annrheumdis-2016-210324","volume":"76","author":"MJ Ombrello","year":"2017","unstructured":"Ombrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Ozen S, et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis. 2017;76:906\u201313.","journal-title":"Ann Rheum Dis"},{"key":"1655_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.pedneo.2015.09.010","volume":"57","author":"LY Xu","year":"2016","unstructured":"Xu LY, Zhang WM, Xia M, Cao LF. Potential effects of interleukins on the pathogenesis of systemic onset juvenile idiopathic arthritis. Pediatr Neonatol. 2016;57:396\u2013401.","journal-title":"Pediatr Neonatol."},{"key":"1655_CR29","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.4049\/jimmunol.1401810","volume":"194","author":"L Ye","year":"2015","unstructured":"Ye L, Jiang B, Deng J, Du J, Xiong W, Guan Y, Wen Z, Huang K, Huang Z. IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation. J Immunol. 2015;194:5110\u20139.","journal-title":"J Immunol."},{"key":"1655_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3899\/jrheum.161534","volume":"45","author":"E Limenis","year":"2018","unstructured":"Limenis E, Feldman BM, Achonu C, Batthish M, Lang B, McLimont M, Ota S, Ramanan A, Scuccimarri R, Young NL, et al. Proposed core set of items for measuring disease activity in systemic juvenile idiopathic arthritis. J Rheumatol. 2018;45:115\u201321.","journal-title":"J Rheumatol"},{"key":"1655_CR31","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Davi S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66:3160\u20139.","journal-title":"Arthritis Rheumatol."},{"key":"1655_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/ard.41.3.259","volume":"41","author":"M Gwyther","year":"1982","unstructured":"Gwyther M, Schwarz H, Howard A, Ansell BM. C-reactive protein in juvenile chronic arthritis: an indicator of disease activity and possibly amyloidosis. Ann Rheum Dis. 1982;41:259\u201362.","journal-title":"Ann Rheum Dis"},{"key":"1655_CR33","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/acr.22215","volume":"66","author":"AF Mourao","year":"2014","unstructured":"Mourao AF, Santos MJ, Melo-Gomes J, Martins FM, Costa JA, Ramos F, Brito I, Duarte C, Figueira R, Figueiredo G, et al. Using the juvenile arthritis disease activity score based on erythrocyte sedimentation rate or C-reactive protein level: results from the Portuguese register. Arthritis Care Res. 2014;66:585\u201391.","journal-title":"Arthritis Care Res."},{"key":"1655_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12969-018-0236-y","volume":"16","author":"M Bielak","year":"2018","unstructured":"Bielak M, Husmann E, Weyandt N, Haas JP, Hugle B, Horneff G, Neudorf U, Lutz T, Lilienthal E, Kallinich T, et al. IL-6 blockade in systemic juvenile idiopathic arthritis-achievement of inactive disease and remission (data from the German AID-registry). Pediatr Rheumatol Online J. 2018;16:22.","journal-title":"Pediatr Rheumatol Online J."},{"key":"1655_CR35","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1056\/NEJMc1301017","volume":"368","author":"F Benedetti De","year":"2013","unstructured":"De Benedetti F. Tocilizumab for systemic juvenile idiopathic arthritis. N Engl J Med. 2013;368:1256\u20137.","journal-title":"N Engl J Med"},{"key":"1655_CR36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13075-017-1462-2","volume":"19","author":"G Horneff","year":"2017","unstructured":"Horneff G, Schulz AC, Klotsche J, Hospach A, Minden K, Foeldvari I, Trauzeddel R, Ganser G, Weller-Heinemann F, Haas JP. Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry. Arthritis Res Ther. 2017;19:256.","journal-title":"Arthritis Res Ther."},{"key":"1655_CR37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/cei.12061","volume":"172","author":"H Imaeda","year":"2013","unstructured":"Imaeda H, Takahashi K, Fujimoto T, Kasumi E, Ban H, Bamba S, Sonoda H, Shimizu T, Fujiyama Y, Andoh A. Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol. 2013;172:410\u20136.","journal-title":"Clin Exp Immunol"},{"key":"1655_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","volume":"7","author":"M Kapoor","year":"2011","unstructured":"Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33\u201342.","journal-title":"Nat Rev Rheumatol"},{"key":"1655_CR39","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/art.40099","volume":"69","author":"C Kessel","year":"2017","unstructured":"Kessel C, Lippitz K, Weinhage T, Hinze C, Wittkowski H, Holzinger D, Fall N, Grom AA, Gruen N, Foell D. Proinflammatory cytokine environments can drive interleukin-17 overexpression by \u03b3\/\u03b4 T cells in systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2017;69:1480\u201394.","journal-title":"Arthritis Rheumatol."},{"key":"1655_CR40","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/art.38647","volume":"66","author":"C Piper","year":"2014","unstructured":"Piper C, Pesenacker AM, Bending D, Thirugnanabalan B, Varsani H, Wedderburn LR, Nistala K. T cell expression of granulocyte-macrophage colony-stimulating factor in juvenile arthritis is contingent upon Th17 plasticity. Arthritis Rheumatol. 2014;66:1955\u201360.","journal-title":"Arthritis Rheumatol."},{"key":"1655_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3892\/mmr.2014.2170","volume":"10","author":"X Ma","year":"2014","unstructured":"Ma X, Wang L, Zhao H, Pang N, Zhang F, Jiang T, Liu X, Mamuti W, Wen H, Ding J. Th17 cells are associated with the Th1\/Th2cell balance during Echinococcus multilocularis infection. Mol Med Rep. 2014;10:236\u201340.","journal-title":"Mol Med Rep."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1655-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1655-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1655-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T19:08:47Z","timestamp":1605208127000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1655-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1655-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]},"assertion":[{"value":"5 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"277"}}